Ferroptosis-related gene transferrin receptor protein 1 expression correlates with the prognosis and tumor immune microenvironment in cervical cancer

• Published in: PeerJ (San Francisco, CA) Vol. 12; p. e17842
• Main Authors: Shang, Xiujuan, Wang, Hongdong, Gu, Jin, Zhao, Xiaohui, Zhang, Jing, Sun, Bohao, Zhu, Xinming
• Format: Journal Article
• Language: English
• Published: United States PeerJ. Ltd 06.08.2024; PeerJ Inc
• Subjects: Analysis; Antigens, CD - genetics; Apoptosis; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Cervical cancer; Development and progression; Female; Ferroptosis; Ferroptosis - genetics; Gene expression; Gene Expression Regulation, Neoplastic; Genes; Genomics; Health aspects; Humans; Immune cell infiltration; Immunohistochemistry; Medical colleges; Medical research; Medicine, Experimental; Messenger RNA; Middle Aged; Prognosis; Prognostic signature; Receptors, Transferrin - genetics; Receptors, Transferrin - metabolism; RNA sequencing; TFRC; Transferrin; Tumor Microenvironment - genetics; Tumor Microenvironment - immunology; Tumors; Uterine Cervical Neoplasms - genetics; Uterine Cervical Neoplasms - immunology; Uterine Cervical Neoplasms - mortality; Uterine Cervical Neoplasms - pathology; Prognostic signature; Immune cell infiltration; Ferroptosis; TFRC; Cervical cancer
• ISSN: 2167-8359; 2167-8359
• DOI: 10.7717/peerj.17842

Ferroptosis is a non-apoptotic iron-dependent form of cell death implicated in various cancer pathologies. However, its precise role in tumor growth and progression of cervical cancer (CC) remains unclear. Transferrin receptor protein 1 (TFRC), a key molecule associated with ferroptosis, has been identified as influencing a broad range of pathological processes in different cancers. However, the prognostic significance of TFRC in CC remains unclear. The present study utilized bioinformatics to explore the significance of the ferroptosis-related gene TFRC in the progression and prognosis of CC. We obtained RNA sequencing data and corresponding clinical information on patients with CC from The Cancer Genome Atlas (TCGA), Genotype Tissue Expression (GTEx) and Gene Expression Omnibus (GEO) databases. Using least absolute shrinkage and selection operator (LASSO) Cox regression, we then generated a multigene signature of five ferroptosis-related genes (FRGs) for the prognostic prediction of CC. We investigated the relationship between TFRC gene expression and immune cell infiltration by employing single-sample GSEA (ssGSEA) analysis. The potential functional role of the TFRC gene was evaluated through gene set enrichment analysis (GSEA). Immunohistochemistry and qPCR was employed to assess TFRC mRNA and protein expression in 33 cases of cervical cancer. Furthermore, the relationship between TFRC mRNA expression and overall survival (OS) was investigated in patients. CC samples had significantly higher TFRC gene expression levels than normal tissue samples. Higher TFRC gene expression levels were strongly associated with higher cancer T stages and OS events. The findings of multivariate analyses illustrated that the OS in CC patients with high TFRC expression is shorter than in patients with low TFRC expression. Significant increases were observed in the levels of TFRC mRNA and protein expression in patients diagnosed with CC. Increased TFRC expression in CC was associated with disease progression, an unfavorable prognosis, and dysregulated immune cell infiltration. In addition, it highlights ferroptosis as a promising therapeutic target for CC.